ADNP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.327840E-01
Normal-vs-Stage2
1.142590E-01
Normal-vs-Stage3
3.694300E-02
Normal-vs-Stage4
5.187600E-01
Stage1-vs-Stage2
8.255600E-01
Stage1-vs-Stage3
1.377180E-01
Stage1-vs-Stage4
3.599600E-01
Stage2-vs-Stage3
1.380430E-01
Stage2-vs-Stage4
4.276800E-01
Stage3-vs-Stage4
5.936000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.019960E-01
Normal-vs-AfricanAmerican
3.538600E-01
Normal-vs-Asian
7.739800E-02
Caucasian-vs-AfricanAmerican
4.337800E-01
Caucasian-vs-Asian
2.422800E-01
AfricanAmerican-vs-Asian
1.779430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.153580E-01
Normal-vs-Female
1.159030E-01
Male-vs-Female
4.366800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.724410E-01
Normal-vs-Age(41-60Yrs)
2.778800E-01
Normal-vs-Age(61-80Yrs)
7.872200E-02
Normal-vs-Age(81-100Yrs)
6.020300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.161800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.197200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.771600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.498000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.639700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.018300E-03
Normal-vs-Daily Drinker
8.767600E-02
Normal-vs-Weekly Drinker
1.819640E-01
Normal-vs-Occasional Drinker
4.258200E-01
Normal-vs-Social Drinker
5.342400E-01
Non Drinker-vs-Daily Drinker
6.087800E-01
Non Drinker-vs-Weekly Drinker
3.182400E-01
Non Drinker-vs-Occasional Drinker
2.670100E-02
Non Drinker-vs-Social Drinker
2.781900E-02
Daily Drinker-vs-Weekly Drinker
6.692400E-01
Daily Drinker-vs-Occasional Drinker
1.023850E-01
Daily Drinker-vs-Social Drinker
7.715900E-02
Weekly Drinker-vs-Occasional Drinker
3.049000E-01
Weekly Drinker-vs-Social Drinker
2.403200E-01
Occasional Drinker-vs-Social Drinker
8.112600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.923700E-02
Normal-vs-Grade 2
2.819900E-02
Normal-vs-Grade 3
3.293900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.744000E-01
Grade 1-vs-Grade 3
6.177600E-01
Grade 1-vs-Grade 4
8.923700E-02
Grade 2-vs-Grade 3
4.427000E-01
Grade 2-vs-Grade 4
2.819900E-02
Grade 3-vs-Grade 4
3.293900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.244400E-02
Normal-vs-NonDiabetic
9.126500E-02
Diabetic-vs-NonDiabetic
4.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.680200E-02
Normal-vs-NoPancreatitis
9.799800E-02
Pancreatitis-vs-NoPancreatitis
5.104800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.264950E-01
Normal-vs-N1
1.140430E-01
N0-vs-N1
7.974600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.465400E-01
Normal-vs-TP53-NonMutant
2.599400E-01
TP53-Mutant-vs-TP53-NonMutant
6.948000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
